NSG 533 ADVANCED PHARMACOLOGY 5
CERTIFICATION EVALUATION TEST 2026 FULL
SOLUTION QUESTIONS GRADED A+
◉ COX-2 inhibitor. Answer: Condition: NSAID ulcer | Medication
(Generic): Celecoxib | Mechanism of Action: ↓ COX-1 injury |
Indication / Use: Risk reduction | Adult Dose: 200 mg daily |
Duration: Chronic | Key Adverse Effects: CV risk | Contraindication
◉ Anticholinergic. Answer: Condition: N/V | Medication (Generic):
Scopolamine | Mechanism of Action: Blocks muscarinic receptors |
Indication / Use: Motion sickness | Adult Dose: Patch q72h |
Duration: PRN | Key Adverse Effects: Dry mouth | Contrai
◉ Antihistamine. Answer: Condition: N/V | Medication (Generic):
Meclizine | Mechanism of Action: H1 blockade | Indication / Use:
Vertigo/motion | Adult Dose: 25-50 mg | Duration: PRN | Key
Adverse Effects: Sedation | Contraindications / Warnings: G
◉ Dopamine antagonist. Answer: Condition: N/V | Medication
(Generic): Metoclopramide | Mechanism of Action: D2 blockade |
Indication / Use: Gastroparesis | Adult Dose: 10 mg QID | Duration:
Short-term | Key Adverse Effects: EPS | Contraindications / Wa
, ◉ Corticosteroid. Answer: Condition: CINV | Medication (Generic):
Dexamethasone | Mechanism of Action: Anti-inflammatory |
Indication / Use: CINV | Adult Dose: Per protocol | Duration: Acute |
Key Adverse Effects: Hyperglycemia | Contraindications
◉ Cannabinoid. Answer: Condition: CINV | Medication (Generic):
Dronabinol | Mechanism of Action: CB1 agonist | Indication / Use:
Refractory CINV | Adult Dose: 2.5-10 mg | Duration: PRN | Key
Adverse Effects: Euphoria | Contraindications / Warnin
◉ Benzodiazepine. Answer: Condition: CINV | Medication (Generic):
Lorazepam | Mechanism of Action: Anxiolytic | Indication / Use:
Anticipatory N/V | Adult Dose: 0.5-2 mg | Duration: PRN | Key
Adverse Effects: Sedation | Contraindications / Warnings:
◉ 5-HT3 antagonist. Answer: Condition: CINV | Medication
(Generic): Ondansetron | Mechanism of Action: Blocks serotonin |
Indication / Use: CINV/PONV | Adult Dose: 4-8 mg | Duration: Acute
| Key Adverse Effects: QT prolongation | Contraindications /
◉ NK1 antagonist. Answer: Condition: CINV | Medication (Generic):
Aprepitant | Mechanism of Action: Blocks substance P | Indication /
Use: Delayed CINV | Adult Dose: Per protocol | Duration: 3 days | Key
Adverse Effects: Fatigue | Contraindications /
CERTIFICATION EVALUATION TEST 2026 FULL
SOLUTION QUESTIONS GRADED A+
◉ COX-2 inhibitor. Answer: Condition: NSAID ulcer | Medication
(Generic): Celecoxib | Mechanism of Action: ↓ COX-1 injury |
Indication / Use: Risk reduction | Adult Dose: 200 mg daily |
Duration: Chronic | Key Adverse Effects: CV risk | Contraindication
◉ Anticholinergic. Answer: Condition: N/V | Medication (Generic):
Scopolamine | Mechanism of Action: Blocks muscarinic receptors |
Indication / Use: Motion sickness | Adult Dose: Patch q72h |
Duration: PRN | Key Adverse Effects: Dry mouth | Contrai
◉ Antihistamine. Answer: Condition: N/V | Medication (Generic):
Meclizine | Mechanism of Action: H1 blockade | Indication / Use:
Vertigo/motion | Adult Dose: 25-50 mg | Duration: PRN | Key
Adverse Effects: Sedation | Contraindications / Warnings: G
◉ Dopamine antagonist. Answer: Condition: N/V | Medication
(Generic): Metoclopramide | Mechanism of Action: D2 blockade |
Indication / Use: Gastroparesis | Adult Dose: 10 mg QID | Duration:
Short-term | Key Adverse Effects: EPS | Contraindications / Wa
, ◉ Corticosteroid. Answer: Condition: CINV | Medication (Generic):
Dexamethasone | Mechanism of Action: Anti-inflammatory |
Indication / Use: CINV | Adult Dose: Per protocol | Duration: Acute |
Key Adverse Effects: Hyperglycemia | Contraindications
◉ Cannabinoid. Answer: Condition: CINV | Medication (Generic):
Dronabinol | Mechanism of Action: CB1 agonist | Indication / Use:
Refractory CINV | Adult Dose: 2.5-10 mg | Duration: PRN | Key
Adverse Effects: Euphoria | Contraindications / Warnin
◉ Benzodiazepine. Answer: Condition: CINV | Medication (Generic):
Lorazepam | Mechanism of Action: Anxiolytic | Indication / Use:
Anticipatory N/V | Adult Dose: 0.5-2 mg | Duration: PRN | Key
Adverse Effects: Sedation | Contraindications / Warnings:
◉ 5-HT3 antagonist. Answer: Condition: CINV | Medication
(Generic): Ondansetron | Mechanism of Action: Blocks serotonin |
Indication / Use: CINV/PONV | Adult Dose: 4-8 mg | Duration: Acute
| Key Adverse Effects: QT prolongation | Contraindications /
◉ NK1 antagonist. Answer: Condition: CINV | Medication (Generic):
Aprepitant | Mechanism of Action: Blocks substance P | Indication /
Use: Delayed CINV | Adult Dose: Per protocol | Duration: 3 days | Key
Adverse Effects: Fatigue | Contraindications /
